Multiple myeloma and infections a populationbased study on

Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients by Cecilie Blimark, Erik Holmberg, Ulf-Henrik Mellqvist, Ola Landgren, Magnus Björkholm, Malin Hultcrantz, Christian Kjellander, Ingemar Turesson, and Sigurdur Y. Kristinsson haematol Volume 100(1): 107 -113 December 31, 2014 © 2015 by Ferrata Storti Foundation

Characteristics of patients with myeloma, and their matched controls. Cecilie Blimark et al. Haematologica

Relative risk of selected infections after diagnosis of myeloma compared to matched controls. Cecilie

Cumulative incidence of first infection over time in myeloma patients and their matched controls.

Risk of infection in myeloma patients compared to controls by calendar periods, and internal comparison by calendar period. Cecilie Blimark et al. Haematologica 2015; 100: 107 -113 © 2015 by Ferrata Storti Foundation

The probability of a first infection during the first and five years after diagnosis/selection stratified by age at diagnosis and calendar period. Cecilie Blimark et al. Haematologica 2015; 100: 107 -113 © 2015 by Ferrata Storti Foundation

Infection-related and non-infection-related death at two months and one year after diagnosis. Cecilie Blimark

The cumulative probability of an infection-related death in all patients computed by competing risk analyses. Cecilie Blimark et al. Haematologica 2015; 100: 107 -113 © 2015 by Ferrata Storti Foundation

The cumulative probability of an infection-related death in patients up to and over 65 years of age at diagnosis, computed with competing risk analyses. Cecilie Blimark et al. Haematologica 2015; 100: 107 -113 © 2015 by Ferrata Storti Foundation